Related Experiment Videos
Hepatitis C in liver transplant patients
1Liver Transplant Unit, Hospital Universitario V. Arrixaca, Muricia, Spain.
Summary
Hepatitis C virus (HCV) infection frequently recurs after liver transplantation. Post-transplant hepatitis C can lead to chronic liver disease, necessitating further study on effective treatments like interferon.
Area of Science:
- Hepatology
- Virology
- Transplantation Immunology
Background:
- Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and liver failure.
- Orthotopic liver transplantation (OLT) is a curative option for end-stage liver disease.
- The recurrence of HCV infection after OLT is a significant concern.
Purpose of the Study:
- To investigate the recurrence rate of HCV infection following OLT.
- To describe the natural history of post-transplantation chronic hepatitis C.
- To evaluate the efficacy of interferon treatment in patients with recurrent HCV after OLT.
Main Methods:
- Retrospective analysis of 70 patients undergoing OLT.
- Serological testing for anti-HCV antibodies before and after OLT.
- Histopathological assessment of liver biopsies in patients with recurrent HCV.
- Interferon therapy administered to a subset of patients with post-transplant hepatitis C.
Main Results:
- HCV recurrence was observed in 20% of OLT recipients (14 out of 70).
- Among patients positive for anti-HCV post-OLT, 57% developed chronic hepatitis.
- Interferon treatment led to normalization of transaminases in 3 out of 4 patients, but 2 experienced severe relapse.
Conclusions:
- Hepatitis C virus infection commonly recurs after orthotopic liver transplantation.
- Post-transplant hepatitis C contributes to significant morbidity.
- Interferon therapy shows potential but requires further investigation for optimal use in OLT recipients.